ASCEND: Contract award for LF MDA and Morbidity Mapping

A Contract Award Notice
by CROWN AGENTS LIMITED

Source
Contracts Finder
Type
Contract (Services)
Duration
15.5 month
Value
£2M
Sector
PROFESSIONAL
Published
11 Jan 2021
Delivery
05 Mar 2020 to 15 Jun 2021
Deadline
04 Dec 2019 23:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Accelerating the Sustainable Control and Elimination of NTDs (ASCEND) is an investment from the UK Government's Foreign, Commonwealth and Development Office (FCDO) to advance the impact and sustainability of national programme's tackling neglected tropical diseases (NTDs). ASCEND in South Asia, East and Southern Africa is implemented by a consortium of technical partners led by Crown Agents. Under the ASCEND programme, Crown Agents has awarded a subcontract to an Implementing Partner (IP) to provide Mass Drug Administration (MDA) and Morbidity Mapping for the treatment of Lymphatic Filariasis (LF), covering sixty-nine districts in nine of the ten regions of Zambia.

Award Detail

1 Akros (Cheyenne)
  • Value: £1,975,105

CPV Codes

  • 73000000 - Research and development services and related consultancy services

Indicators

  • Contract is suitable for SMEs.
  • Contract is suitable for VCOs.

Reference

Domains